PHARMACY software supplier
Corum Group has reported its
results for the six months to 31
Dec, with after-tax profit improving
32.15 to $3.371 million.
Revenue was unchanged from the
previous corresponding period at
$10.87 million, with the Corum
Health Services software division
producing a $1.82m operating
profit - a huge improvement on the
previous result of $119,000 which
included a non-recurring expense
of $968,000 for impairment of
software development costs.
“All segments of this division
improved compared to last year,”
the company said.
Corum’s directors have announced
the declaration of an unfranked
dividend of .6 cents per ordinary share.The above article was sent to subscribers in Pharmacy Daily's issue from 22 Feb 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Feb 13
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.